Invest Cannabis Asia

Since joining Medivie Therapeutic on October 2018, Inbar has set the goal to enable Medivie an international growth in producing, extracting and marketing of medical, recreational and cosmetics adjusted cannabis.
As a LL.B graduate with more than three years of experience in the field of capital market and securities law, Inbar offers the company the legal support and guidance in Israel and abroad.

For the last 4 years, Yona has been the CEO of Alvit LCS Pharma, a leading Israeli medical cannabis drug delivery company established to produce safer, more convenient and more effective medicinal cannabis products for patients and their treating physicians through superior proprietary cultivation, extraction and formulation technologies. In addition, Yona also currently serves as a Director of Alvit’s daughter company Tefen, an Israel based cannabis cultivation farm that publicly trades on the Tel Aviv Stock Exchange (TLE:TEFN).
Mr. Levy also has extensive experience in the capital markets, having founded Levy Capital Group, a boutique investment house that specializes in providing investment opportunities in the U.S. and Israeli markets to both large Israeli banks and high net worth individuals. Levy Capital's investments include US stocks, private companies, start-ups, and Israeli real estate development projects.

Mr. Brod was appointed as the MD of Netafim South East Asia in January 2018. Prior to this role he was the Netafim APAC CFO since 2014 and before that he acted as the Netafim ANZ CFO since 2009.
He has a diverse background acting in different roles and industries which include sales and marketing in Telecommunications, accounting in automotive, Financial planning & Analysis in the power industry, Strategic pricing in Telecommunication and finance & management in the Agriculture industry.

Founded in 2017, Jacana exclusively cultivates sun-grown medical cannabis, leveraging its proprietary genetics for equatorial climates and currently distributes its products in Canada.

Joining Jacana in March 2018 as Vice President of Business Development, Markus Hoffmann is a lawyer by training with a background in private equity and cannabis investment, including an engagement with the Dutch cultivator Bedrocan International. His current focus is to establish a global platform for the cultivation, extraction and formulation of boutique, EU-GMP grade medical cannabis products through collaborations in the Caribbean, Africa, EU and Southeast Asia.

As CEO and founder of MC Therapeutics, Tristan is dedicated to the pursuit of environmentally sustainable and organically grown cannabis. After seeing the benefits first hand to friends growing up in Canada and the additional complications and unnecessary side effects patients experienced from improperly grown cannabis, he knew change was required.
Tristan sits on the advisory board for Greenfield Medicinal Cannabis (a licenced Australian importer and distributor) and brings 4 years’ experience in large scale manufacturing, working for Australia’s largest health food company in a variety of roles including Quality Assurance and Research and Development. His entrepreneurial experience includes involvement in the health and fitness industry with his protein and supplements company and fitness centers.

Dr. Somyot continues to incubate and lead public discussion on legalization and development of the cannabis industry in Thailand.

Author of TWO books stimulating national discussion to support the legalization of Cannabis in the Kingdom of Thailand.

Ron Lipsky entered the Medical Cannabis field in Israel following a twenty year career in film, tv and event production in the US. He joined MGC in 2014. His talents in networking, communication and production lend themselves to his role finding MGC projects around the globe to further the company's strategy, as well his involvement in coordinating and furthering the the MGC Derma brand globally.

Rowan is co founder of Fire-Seed Hemp Beverages. The company is headquartered in Beijing and makes a range of hemp drink products for the domestic Chinese market. Rowan is an active investor and advisor in the Biotech, IT and F&B space.

Dr. Oraphan is a member of Thailand's national Medical Council. As a medical professional with more then 25 years experience, she is a passionate advocate dedicated to Thailand supporting the use of medicinal cannabis and funding for more intensive local research including genetics mapping and clinical trials.

As Medical Director of Cannabis Access Clinics, Dr. Nijhawan is working with doctors throughout Australia establishing protocols for appropriately prescribing medical cannabis.

With more then 20 years of medical and entrepreneurial experience, Dr, Nijhawan was previously Head of Clinical Development at Primary Healthcare. Earlier in his career DR Sanjay was medical director and practice principal at a number of general medical practices around Australia.

Ben joined the Canopy Growth family in late 2017, tasked with establishing Canopy Growths international medical brand, Spectrum Cannabis, Asia Pacific headquarters (APAC HQ) located in Victoria, Australia.
Spectrum Cannabis APAC HQ will focus on domestic cultivation and production of high quality medical cannabis while serving as a distribution hub for APAC as other jurisdictions within the region establish legal, regulated medical cannabis regimes. It will also operate as the APAC Research and Development Center for the company, supporting the ongoing research collaboration between Spectrum Cannabis Australia and Agriculture Victoria on innovations in medical cannabis cultivation and production.

Gained from his 18 years in the technology space, Ben brings with him a wealth of experience opening and developing emerging markets, during which time Ben was responsible for establishing new markets across Europe, Middle East and Africa (EMEA), South East Asia and Australia. Most recently Ben was the Regional Managing Director for Research in Motion (BlackBerry) based in Kuala Lumpur, Malaysia overseeing the Indochina region, before returning to Australia with his family in early 2015, which he spent time with both Optus and SAP.

Having lived and worked internationally, Ben understands the many challenges corporations face in the complex global business environment. Ben thrives upon the challenges that come with establishing a new industry or business and brings forward a unique and authentic approach to delivering results and overcoming obstacles

As Founder and CEO of Farma Trust, Raja is driving the company’s vision and mission of protecting the
vulnerable by eliminating deadly counterfeit medications on a global scale.
Raja is a UK qualified barrister with over 20 years business experience in the global media and technology
industries and holds Masters of Law from University of Nottingham. Before establishing Farma Trust, his
most recent groundbreaking global digital media achievements include the strategic planning, launch and
operational management of Al Jazeera Media Network’s digital current affairs media products aimed at
millennials: AJ+ (USA), AJ+ (Spanish) and AJ+ (Arabi), engaging millions of young people across the
world.

Fleta Solomon has spent her career changing people’s lives for the better.

Over a 10-year period, Fleta established, grew and sold one of Australia’s largest providers of workplace health services positively changing the health behaviours of more than 50,000 Australian workers.

She has since been involved in several start-ups in the health improvement space including a water treatment technology concept to assist the billions of people worldwide without safe access to clean drinking water.

Fleta is now the Managing Director at Little Green Pharma, the first company in Australia to produce locally grown medicinal cannabis products for patient use.

With a degree in exercise and health science, an MBA and a graduate of the Australian Institute of Company Directors, Fleta has a vision to continue improving the thousands of patients worldwide who can benefit from cannabinoid therapy.

Dr. Veronica Stahl is an entrepreneur with 10 year experience in EU market. Additional, she is an experienced dental professional with 23 years of clinical practice history. As a hands-on leader in the dental implants industry, Dr. Stahl has delivery optimum care and led teams of medical organization in delivering optimum care for patients. Her expertise in the field of implantology, endodontics and restorative dentistry with bright the scientific underpinnings enabling a high integrity organization of science-backed treatments. Dr. Stahl is founder of Cannabite Life Long. Company based on First Worldwide Personalized Oral Care Solutions based on Cannabis Extracts. This is a Breakthrough in the World of Dentistry and Medical pharmaceutical developments.

Veronica is known as a visionary and natural born leader. Her ability to see the best potential in any scenario while understanding the clear challenges associated make her a realistic and determined entrepreneur. Rooted in a desire to created simple solution that leverage the lasted technologies and the most natural of approached, she is a great fit for this mission and will guide the team through challenges and successes with high integrity and ethics.